A clinical experience with Gengraf™ (Abbott cyclosporine) in de novo renal transplant recipients.

被引：0
|
作者：
Scandling, J
Rajagopalan, PR
Magee, J
Conti, D
Mendez, R
Bronson, D
Awni, W
Nabulsi, A
Hoffman, R
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Natl Inst Transplantat, Los Angeles, CA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
184
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] Screening for hypomagnesemia in cyclosporine or FK 506 treated renal transplant recipients.
    Gupta, BK
    Glicklich, D
    TRANSPLANTATION, 1999, 67 (07) : S152 - S152
  • [32] Influence of cyclosporine exposure on the pharmacokinetics of mycophenolic acid in renal transplant recipients.
    Sudchada, Patcharaporn
    Gundroo, Aijaz
    Donneally, Julie
    DeFrancesco, Robin
    Hochreiter, Jill
    Venuto, Rocco
    Tornatore, Kathleen M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 593 - 593
  • [33] A pharmacokinetic conversion study of Abbott cyclosporine and Neoral® in stable renal transplant recipients
    Tomlanovich, S
    Pollak, R
    Roza, A
    Merion, R
    Scandling, J
    Greco, R
    Dubé, L
    Awni, W
    Nabulsi, A
    TRANSPLANTATION, 1999, 67 (07) : S163 - S163
  • [34] Therapeutic Management and Outcome of the Novo Prostate Cancer in Renal Transplant Recipients.
    Carta, P.
    Zanazzi, M.
    Villari, D.
    Detti, B.
    Nicita, G.
    Minetti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 298 - 298
  • [35] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [36] Features of ''de novo'' HCV infection in heart transplant (HTx) recipients.
    Fagiuoli, S
    DeMaria, N
    Colantoni, A
    Faruki, H
    VanThiel, DH
    Cooper, DKC
    Zuhdi, N
    GASTROENTEROLOGY, 1996, 110 (04) : A1188 - A1188
  • [37] De novo post-transplant malignancies in liver transplantation recipients.
    Boin, IF
    Leonardi, MF
    Ataide, EC
    Leonardi, LS
    LIVER TRANSPLANTATION, 2004, 10 (06) : C15 - C15
  • [38] De novo breast cancer in renal transplant recipients
    Buell, JF
    Hanaway, MJ
    Trofe, J
    Gross, TG
    Beebe, TM
    Alloway, RR
    First, MR
    Woodle, ES
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1778 - 1779
  • [39] Bone biomarkers in de novo renal transplant recipients
    Evenepoel, Pieter
    Cavalier, Etienne
    D'Haese, Patrick C.
    CLINICA CHIMICA ACTA, 2020, 501 : 179 - 185
  • [40] De Novo Urologic Malignancies in Renal Transplant Recipients
    Antunes, H.
    Tavares-da-Silva, E.
    Oliveira, R.
    Carvalho, J.
    Parada, B.
    Bastos, C.
    Figueiredo, A.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1348 - 1354
12345